Heterophilic antibodies in human serum can react with the immunoglobulins included in the assay components causing interference with immunoassay.
For Tosoh AIA immunoassay method performed at Weston lab, the drug asfotase alfa (Strensiq®), used for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP), may cause falsely increased or decreased test results. Test results from patients treated with asfotase alfa should be interpreted with respect to the clinical picture of the patient. Recommend sending test to Marshfield Center lab for analysis by an alternate method.